The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
German Adjuvant Intergroup Node Positive (GAIN) study: A phase III trial to compare IDD-ETC versus EC-TX in patients with node-positive primary breast cancer—Final efficacy analysis.
Volker Jochen Moebus
Honoraria - Amgen; Celgene; Roche
Research Funding - Amgen; Roche
Gunter Von Minckwitz
Consultant or Advisory Role - Amgen; Roche
Honoraria - Amgen; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Roche
Christian Jackisch
No relevant relationships to disclose
Hans-Joachim Lueck
Honoraria - Amgen; Novartis; Roche
Andreas Schneeweiss
Consultant or Advisory Role - Celgene; Medac; Roche
Honoraria - AstraZeneca; Celgene; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche
Research Funding - Celgene; Roche
Hans Tesch
Honoraria - Amgen
Dirk Elling
No relevant relationships to disclose
Nadia Harbeck
Consultant or Advisory Role - Celgene; Roche
Honoraria - Celgene; Novartis; Roche
Research Funding - Amgen; Celgene; Genomic Health; Roche; Teva
Bettina Conrad
No relevant relationships to disclose
Tanja Fehm
No relevant relationships to disclose
Jens Bodo Huober
Consultant or Advisory Role - GlaxoSmithKline; Roche; Sanofi
Honoraria - Roche
Research Funding - GlaxoSmithKline
Volkmar Müller
Consultant or Advisory Role - Amgen; Celgene; Roche
Honoraria - Amgen; Celgene; Janssen-Cilag; Pierre Fabre Medicament; Roche
Ingo Bauerfeind
Honoraria - Bristol-Myers Squibb
Marcus Schmidt
Consultant or Advisory Role - Roche
Stock Ownership - Roche
Honoraria - Roche
Sibylle Loibl
Honoraria - Amgen; Roche
Valentina Nekljudova
No relevant relationships to disclose
Michael Untch
No relevant relationships to disclose
Christoph Thomssen
Honoraria - Amgen; Roche